Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Public ClinicalTrials.gov record NCT00447499. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi Center Open Label Study to Assess the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Study identification
- NCT ID
- NCT00447499
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Ipsen
- Industry
- Enrollment
- 59 participants
Conditions and interventions
Conditions
Interventions
- Somatuline Autogel (lanreotide acetate) Drug
- Home administration Behavioral
Drug · Behavioral
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2007
- Primary completion
- Nov 30, 2008
- Completion
- Nov 30, 2008
- Last update posted
- Nov 19, 2020
2007 – 2008
United States locations
- U.S. sites
- 13
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Diabetes and Endocrine Associates | La Mesa | California | 91942 | — |
| Cedars Sinai Medical Center | Los Angeles | California | 90048 | — |
| Denver VA Medical Center | Denver | Colorado | 80220 | — |
| Northwestern University The Feinberg School of Medicine | Chicago | Illinois | 60611 | — |
| Johns Hopkins University | Baltimore | Maryland | 21287 | — |
| Massachussetts General Hospital | Boston | Massachusetts | 02114 | — |
| NYU School of Medicine | New York | New York | 10010 | — |
| Columbia University | New York | New York | 10032 | — |
| Sisters of Charity Hospital, Buffalo | Williamsville | New York | 14221 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| Research Institute of Dallas | Dallas | Texas | 75231 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| University of Texas M.D. Anderson Cancer Center | Houston | Texas | 77230 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00447499, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 19, 2020 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00447499 live on ClinicalTrials.gov.